This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kelbæk, H. Search for Related Content PubMed PubMed Citation Articles by Kelbæk, H.

The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial

Henning Kelbæk, MD^_*,_*, Leif Thuesen, MD, Steffen Helqvist, MD^_*, Lene Kløvgaard, RN^_*, Erik Jørgensen, MD^_*, Samir Aljabbari, MD^_*, Kari Saunamäki, MD^_*, Lars R. Krusell, MD, Gunnar V.H. Jensen, MD, Hans E. Bøtker, MD, Jens F. Lassen, MD, Henning R. Andersen, MD, Per Thayssen, MD, Anders Galløe, MD^||, Anton van Weert, PhD^¶ SCANDSTENT Investigators

^_* Rigshospitalet, Copenhagen, Denmark
Skejby Sygehus, Skejby, Denmark
Roskilde Amtssygehus, Roskilde, Denmark
Odense Universitets hospital, Odense, Denmark
^|| Gentofte Amtssygehus, Gentofte, Denmark
^¶ Heart Core, Leiden, the Netherlands

View larger version (17K): [in a new window]   Figure 1 Cumulative frequency of the minimal lumen diameter before (pre), immediately after (post), and six months after (follow-up) stent implantation in patients who received sirolimus-eluting and bare-metal stents.

View larger version (13K): [in a new window]   Figure 2 Kaplan-Meier estimates of event-free survival among patients who received sirolimus-eluting and bare-metal stents.

View larger version (22K): [in a new window]   Figure 3 Subgroup analysis for the six-month rate of target lesion revascularization. CI = confidence interval; CX = circumflex; LAD = left anterior descending; RCA = right coronary artery.